Pre-clinical toxicity studies of IV use (bolus) of P2G12 were completed on rats at doses of 7 and 35mg/kg (equivalent to 490mg and 2.45g for a 70Kg human respectively). No adverse events were observed up to 14 days post-administration, no safety concerns were raised.